Thiol-mediated ROS-responsive hydrogel with arginine-driven NO cascade for colitis treatment
Materials Today Bio · 2026-10 · 40 · 103576
DOI: 10.1016/j.mtbio.2026.103576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2026-10. Verfasst von Shuang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, North China University of Science and Technology, Tangshan, 063210, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Developing integrated, drug-free therapeutic platforms that simultaneously address oxidative stress, immune dysregulation, and gut microbiota dysbiosis remains a significant challenge in UC management. Although hydrogels offer localized delivery advantages, their clinical versatility is frequently hindered by a reliance on exogenous drug encapsulation. To overcome this limitation, we developed a multifunctional, ROS-responsive hydrogel (ODCAS) that functions as an inherently bioactive platform. The ODCAS network is constructed via dynamic Schiff base crosslinking between ODex and thiolated arginine chitosan, further reinforced by ROS-triggered disulfide bonds leveraging. This sophisticated architecture undergoes ROS-responsive programmed degradation, driving in situ NO generation to trigger a therapeutic cascade. Specifically, the TPA-derived thiol moieties facilitate inflammation-targeted mucoadhesion via disulfide exchange with the mucosal layer, while simultaneously providing potent, direct ROS scavenging (72.21 ± 2.47% DPPH· radical scavenging). Furthermore, the metabolic byproducts of the hydrogel network provide prebiotic support to restore microbial equilibrium. In a DSS-induced murine colitis model, oral administration of ODCAS significantly attenuated disease severity, reducing the DAI by 52.08%, downregulating pro-inflammatory cytokines, and restoring both intestinal barrier integrity and microbial homeostasis. These findings highlight the ODCAS hydrogel as a robust, ROS-responsive biomaterial platform that orchestrates disulfide-mediated anchoring and an arginine-driven NO cascade for the effective management of chronic inflammatory diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, North China University of Science and Technology, Tangshan, 063210, China.
- School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, China.
- Hebei Key Laboratory for Rehabilitation Engineering and Regenerative Medicine, School of Nursing and Rehabilitation, North China University of Science and Technology, Tangshan, 063210, China.
- State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300350, China.
- Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin University, Tianjin, 300350, China.
Förderung
- Natural Science Foundation of Hebei Province
Zitieren
APA
Liu, S., Zhao, Z., Wang, Z., Pi, X., Zhao, W., Hu, H., He, X., Che, P., Li, J., & Sun, H. (2026). Thiol-mediated ROS-responsive hydrogel with arginine-driven NO cascade for colitis treatment. Materials Today Bio, 40, 103576. https://doi.org/10.1016/j.mtbio.2026.103576
Vancouver
Liu S, Zhao Z, Wang Z, Pi X, Zhao W, Hu H, et al. Thiol-mediated ROS-responsive hydrogel with arginine-driven NO cascade for colitis treatment. Materials Today Bio. 2026;40:103576. doi:10.1016/j.mtbio.2026.103576
BibTeX
@article{Liu2026,
author = {Liu, Shuang and Zhao, Zhongming and Wang, Ziyi and Pi, Xianghe and Zhao, Weiqin and Hu, Huiju and He, Xinmei and Che, Pengcheng and Li, Junjie and Sun, Hong},
title = {Thiol-mediated ROS-responsive hydrogel with arginine-driven NO cascade for colitis treatment},
journal = {Materials Today Bio},
year = {2026},
volume = {40},
pages = {103576},
doi = {10.1016/j.mtbio.2026.103576}
}
EUVIMED